Effects of flavangenol, an extract of French maritime pine bark on collagen-induced arthritis in rats

Journal of Nutritional Science and Vitaminology

Volumn 57, Issue 3, 2011, Pages 251-257

  Tsubata, Masahito ^a   Takagaki, Kinya ^a   Hirano, Shin Ichi ^b   Iwatani, Koichi ^b   Abe, Chiyuki ^c  

^a Research and Development Division   (Japan)

^b Mercian Cleantec Corporation   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti inflammation; Collagen induced arthritis; Flavangenol; Nitric oxide; Pine bark extract

Indexed keywords

COLLAGEN; FLAVANGENOL; IBUPROFEN; PLANT EXTRACT; PROANTHOCYANIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; NONHUMAN; PINE; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BIFLAVONOIDS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FEMALE; NITRIC OXIDE; PHYTOTHERAPY; PINUS; PLANT BARK; PLANT EXTRACTS; PROANTHOCYANIDINS; RATS; RATS, INBRED STRAINS;

PINUS PINASTER; RATTUS;

EID: 80052757677     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.57.251     Document Type: Article

References (33)

1. Firestein GS. 2001. Etiology and pathogenesis of rheumatoid arthritis. In: Kelly's Textbook of Rheumatology (Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, eds), Vol 2, p 921-926. WB Saunders, Philadelphia.
2. Shiokawa Y, Horiuchi Y, Mizushima Y, Kageyama T, Shichikawa K, Ofuji T, Honma M, Yoshizawa H, Abe C, Ogawa N. 1984. A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. J Rheumatol 11: 615-623.
3. Yasuda M, Nonaka S, Wada T, Yamamoto M, Shiokawa S, Suenaga Y, Nobunaga M. 1994. Additive two DMARD therapy of the patients with rheumatoid arthritis. Clin Rheumatol 13: 446-454.
4. Schuna AA, Megeff C. 2000. New drugs for the treatment of rheumatoid arthritis. Am J Health Syst Pharm 57: 225-234.
5. Santana-Sabagun E, Weisman MH. 2001. Nonsteroidal anti-inflammatory drugs. In: Kelly's Textbook of Rheumatology (Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, eds), Vol 1, p 799-822. WB Saunders, Philadelphia.
6. Hua J, Suguro S, Hirano S, Sakamoto K, Nagaoka I. 2005. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res 54: 127-132.
7. Abe C, Fujita K, Kikuchi E, Hirano S, Kuboki H, Yamashita A, Hashimoto H, Mori S, Okada M. 2004. Effects of _-linked galactooligosaccharide on adjuvantinduced arthritis in Wistar rats and type II collageninduced arthritis in DBA1/J mice. Int J Tissue React 26: 65-73.
8. Hatori M, Ohki K, Hirano S, Yang XP, Kuboki H, Abe C. 2008. Effects of casein hydrolysate prepared from Aspergillus oryzae protease on adjuvant arthritis in rats. Biosci Biotechnol Biochem 72: 1983-1991.
9. Ikeguchi M, Tsubata M, Tabata A, Takagaki K. 2006. Effects of pine bark extract on lipid metabolism in rats. J Jpn Soc Nutr Food Sci 59: 89-95.
10. Hellstrom JK, Mattila PH. 2008. HPLC determination of extractable and unextractable proanthocyanidins in plant materials. J Agric Food Chem 56: 7617-7624.
11. Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritime) bark, Pycnogenol. Free Radic Biol Med 27: 704-724.
12. Sato M, Yamada Y, Matsuoka H, Nakashima S, Kamiya T, Ikeguchi M, Imaizumi K. 2009. Dietary pine bark extract reduces atherosclerotic lesion development in male ApoE-deficient mice by lowering the serum cholesterol level. Biosci Biotechnol Biochem 73: 1314-1317.
13. Kamuren ZT, McPeek RA, Watkins JB. 2006. Effects of low-carbohydrate diet and Pycnogenol treatment on retinal antioxidant enzymes in normal and diabetic rats. J Ocul Pharmacol Ther 22: 10-18.
14. Maritim A, Dene BA, Sanders RA, Watkins JB. 2003. Effects of Pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 17: 193-199.
15. Liu X, Wei J, Fengsen T, Shengming Z, Wurthwein G, Rohdewald P. 2004. Pycnogenol, French maritime pine bark extract, improves entothelial function of hypertensive patients. Life Sci 74: 855-862.
16. Blazso G, Rohdewald P, Sibbel R, Gabor M. 1995. Antiinflammatory activity of procyanidin-containing extracts from Pinus pinaster sol. In: Proceedings of the International Bioflavonoid Symposium, p 231-238. Vienna, Austria.
17. Slme S, Reeve VE. 2004. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by tropical Pycnogenol. Photochem Photobiol 79: 193-198.
18. Farid R, Mirfeizi Z, Mirheidari M, Rezaieyazdi Z, Mansouri H, Esmaelli H, Zibadi S, Rohdewald P, Watson RR. 2007. Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. Nutr Res 27: 692-697.
19. Kwak C-J, Kubo E, Fujii K, Nishimura Y, Kobuchi S, Ohkita M, Yoshimura M, Kiso Y, Matsumura Y. 2009. Antihypertensive effect of French maritime pine bark extract (Flavangenol): possible involvement of endothelial nitric oxide-dependent vasorelaxation. J Hypertens 27: 92-101.
20. Hirano S, Wakazono K, Agata N, Mase T, Yamamoto R, Matsufuji M, Sakata N, Iguchi H, Tone H, Ishizuka M, Takeuchi T, Abe C. 1994. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA1/J mice and adjuvant arthritis in Lewis rats. Int J Tissue React 16: 155-162.
21. Agata N, Hirano S, Abe C, Nakashima T, Tsuchiya A, Kumagai H, Isshiki K, Yoshioka T, Ishizuka M, Takeuchi T. 2000. Suppression of type II collagen-induced arthritis by a new isocoumarin, NM-3. Res Commun Mol Pathol Pharmacol 108: 297-309.
22. Abe C, Hirano S, Wakazono K, Mase T, Yamamoto R, Matsufuji M, Sakata N, Agata N, Iguchi H, Ishizuka M, Takeuchi T. 1995. Effects of cytogenin on spontaneous arthritis in MRL/l mice and on pritane-induced arthritis (PIA) in DBA/1J mice. Int J Tissue React 17: 175-180.
23. Trentham DE, Townes AS, Kang AH. 1977. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146: 857-868.
24. Abe C, Kikukawa T, Komatsu Y, Goto M, Fujihira E, Hirano S. 1995. Quality of arthritis: early articular lesions in experimental animal models for arthritis. Jpn J Inflamm 15: 395-399 (in Japanese).
25. Fermor B, Christensen SE, Youn I, Cernanec JM, Davies CM, Weinberg JB. 2007. Oxygen, nitric oxide and articular cartilage. Eur Cells Mater 13: 56-65.
26. Jang D, Murrell GAC. 1998. Nitric oxide in arthritis. Free Radic Biol Med 24: 1511-1519.
27. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. 1996. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 1519-1524.
28. Connor JR, Manning PT, Settle SL. 1995. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide. Eur J Pharmacol 273: 15-24.
29. Lalenti A, Moncada S, Rosa MD. 1993. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 110: 701-706.
30. Virgili F, Kobuchi H, Packer L. 1998. Procyanidins extracted from Pinus maritima (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages. Free Radic Biol Med 24: 1120-1129.
31. Park YC, Rimbach G, Saliou C, Valacchi G, Packer L. 2000. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-α secretion, and NF-κB-dependent gene expression in RAW 164.7 macrophages. FEBS Lett 465: 93-97.
32. Mackenzie GG, Delfino JM, Keen CL, Fraga CG, Oteiza PI. 2009. Dimetric procyanidins are inhibitors of NF-κBDNA binding. Biochem Pharmacol 78: 1252-1262.
33. Mochizuki M, Hasegawa N. 2004. Therapeutic efficacy of Pycogenol in experimental inflammatory bowel disease. Phytother Res 18: 1027-1028.